Last reviewed · How we verify
NCT05929196
Feasibility Evaluation - Blood Glucose Level Monitoring by Microwave Metamaterial Sensor in Blood Samples.
NA trial testing In vitro full blood diagnostic test. in Diabetes in 21 participants. Completed in 1 September 2023.
17 July 2023
Quick facts
| Lead sponsor | Czech Technical University in Prague |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | basic science |
| Enrollment | 21 |
| Start date | 12 July 2023 |
| Primary completion | 17 July 2023 |
| Estimated completion | 1 September 2023 |
| Sites | 1 location across Czechia |
Drugs / interventions tested
- In vitro full blood diagnostic test.
Conditions studied
- Diabetes — all drugs for Diabetes →
Sponsor
Czech Technical University in Prague
Who can join
18 and older, any sex, with Diabetes. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this clinical trial is to test microwave metamaterial glucose sensor on blood samples. It means to compare the results of glucose values obtained by microwave metamaterial sensor and by standard biochemical analyzer.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05929196
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Diabetes
Currently open trials in the same condition.
- NCT07272837 — Impact of Semaglutide (Ozempic/Wegovy®) on Heart and Muscle Mass · recruiting
- NCT07479134 — Production of Stem Cells for the Generation of Pancreatic Cells · NA · recruiting
- NCT07441655 — Families Implementing Good Health Traditions for Life · NA · recruiting
- NCT06724172 — CHIME: Comparing Health Interventions for Maternal Equity · NA · recruiting
- NCT07417865 — ECHO Diabetes FQHC · recruiting
Other Czech Technical University in Prague trials
Trials by the same sponsor.
- NCT06817850 — Neonatal Oximeter Bias Study · not yet recruiting
- NCT06626217 — Comparison of Perfusion Index Monitoring Using a Smartwatch and a Pulse Oximeter · NA · not yet recruiting
- NCT06635018 — Effect of Pulse Oximeter Device on Measured Perfusion Index Values · NA · completed
- NCT06098092 — Long-term Accuracy and Stability of Blood Pressure Measurements From a Smartwatch: Prospective Validation Study · NA · completed
- NCT05943912 — Myopia Control Effect of DIMS Spectacle Lenses in Czech Children and Young Adults · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05929196 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Czech Technical University in Prague
- Last refreshed: 28 February 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05929196.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing